CXCR2 and liver cancer: To determine the functional relevance of this finding, we reanalyzed Hoshida Golub Liver GSE10143 (n = 162) data and demonstrated that the high expression of CXCR2 and CXCL6 was associated with worse overall survival in patients with liver cancer (Figure 1C).